Selective cyclooxygenase-2 inhibitors: Pharmacology, clinical effects and therapeutic potential

Expert Opinion on Investigational Drugs

Volumn 6, Issue 5, 1997, Pages 609-614

  Van Ryn, J ^a   Pairet, M ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

cyclooxygenase 1 and 2; gastrointestinal side effects; nonsteroidal anti inflammatory drugs; osteoarthritis; rheumatoid arthritis

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB; UNCLASSIFIED DRUG;

CLINICAL TRIAL; CONFERENCE PAPER; DIGESTIVE SYSTEM INJURY; DRUG EFFICACY; DRUG RESEARCH; GASTROINTESTINAL SYMPTOM; HUMAN; INFLAMMATION; OSTEOARTHRITIS; RHEUMATOID ARTHRITIS;

EID: 0030911724     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.6.5.609     Document Type: Conference Paper

References (20)